Home/Filings/4/0001144204-13-026764
4//SEC Filing

Tuttle Craig James 4

Accession 0001144204-13-026764

CIK 0001043961other

Filed

May 6, 8:00 PM ET

Accepted

May 7, 2:41 PM ET

Size

9.9 KB

Accession

0001144204-13-026764

Insider Transaction Report

Form 4
Period: 2013-05-03
Tuttle Craig James
DirectorPresident and CEO
Transactions
  • Award

    Purchase Option

    2013-05-03+83,33383,333 total
    Exercise: $0.35From: 2015-06-01Exp: 2023-05-02Common Stock (83,333 underlying)
  • Award

    Purchase Option

    2013-05-03+83,33383,333 total
    Exercise: $0.35From: 2016-06-01Exp: 2023-05-02Common Stock (83,333 underlying)
  • Award

    Purchase Option

    2013-05-03+83,33483,334 total
    Exercise: $0.35From: 2014-06-01Exp: 2023-05-02Common Stock (83,334 underlying)
Footnotes (2)
  • [F1]Common Stock, par value $.01 per share of Transgenomic, Inc.
  • [F2]The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitles the reporting person to purchase up to an aggregate of 250,000 shares of Common Stock, par value $.01 per share of Transgenomic, Inc.

Issuer

TRANSGENOMIC INC

CIK 0001043961

Entity typeother

Related Parties

1
  • filerCIK 0001368793

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 2:41 PM ET
Size
9.9 KB